Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial
Open Access
- 16 February 2026
- journal article
- research article
- Published by Elsevier in The Lancet Global Health
- Vol. 14 (3) , e386-e394
Abstract
No abstract availableKeywords
Funding Information
- University of Nottingham
- Tertiary Education Trust Fund (D/CE/NFR/STI/28/VOL1)
This publication has 25 references indexed in Scilit:
- Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatmentNitric Oxide, 2024
- Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control studyThe Lancet Haematology, 2022
- Antiplatelet therapy before or after 16 weeks’ gestation for preventing preeclampsia: an individual participant data meta-analysisAmerican Journal of Obstetrics and Gynecology, 2017
- Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin StudyJournal of Perinatology, 2014
- International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st ProjectThe Lancet, 2014
- Seven myths of randomisation in clinical trialsStatistics in Medicine, 2012
- Pregnancy outcome in patients with homozygous sickle cell disease in a university hospital, Eastern Saudi ArabiaArchives of Gynecology and Obstetrics, 2009
- Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient dataThe Lancet, 2007
- Antiplatelet agents for preventing pre-eclampsia and its complicationsCochrane Database of Systematic Reviews, 2007
- Trial of low doses of aspirin as prophylaxis insickle cell diseaseThe Journal of Pediatrics, 1983